Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Defence Therapeutics A (DTCFF)

Defence Therapeutics A (DTCFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Defence Therapeutics to Showcase Accum Platform at Key International Industry Events in March Newsfile - Mon Mar 2, 2:20AM CST

Montreal, Quebec--(Newsfile Corp. - March 2, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology company advancing next-generation...

DTCFF : 0.4400 (-8.33%)
DTC.CN : 0.6400 (+1.59%)
Defence Therapeutics Announces Private Placement of Units for Proceeds of up to $11 Million Newsfile - Fri Feb 27, 4:12PM CST

Montreal, Quebec--(Newsfile Corp. - February 27, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular...

DTCFF : 0.4400 (-8.33%)
DTC.CN : 0.6400 (+1.59%)
Defence Therapeutics Aligns Accum ADC Strategy Through Multidisciplinary Scientific Advisory Board Newsfile - Tue Feb 10, 2:18AM CST

Montreal, Quebec--(Newsfile Corp. - February 10, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular...

DTCFF : 0.4400 (-8.33%)
DTC.CN : 0.6400 (+1.59%)
Defence Therapeutics to Present at the World ADC Europe 2026 Showcasing Accum Precision Intracellular Drug-Delivery Platform Newsfile - Wed Feb 4, 2:16AM CST

Montreal, Quebec--(Newsfile Corp. - February 4, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular...

DTCFF : 0.4400 (-8.33%)
DTC.CN : 0.6400 (+1.59%)
Defence Therapeutics Expands Collaboration with Canadian Nuclear Laboratories to Accelerate Its Proprietary Radiopharmaceutical Pipeline Newsfile - Wed Jan 28, 7:52AM CST

Montreal, Quebec--(Newsfile Corp. - January 28, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular...

DTCFF : 0.4400 (-8.33%)
DTC.CN : 0.6400 (+1.59%)
Defence Therapeutics Sharpens Strategic Focus on Precision Drug Delivery to Unlock the Full Potential of Cancer Biologics Newsfile - Wed Jan 21, 2:16AM CST

Montreal, Quebec--(Newsfile Corp. - January 21, 2026) - Defence Therapeutics Inc., (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology company, today announced...

DTCFF : 0.4400 (-8.33%)
DTC.CN : 0.6400 (+1.59%)
Defence Therapeutics Announces AGM Results and Provides Corporate Updates Newsfile - Wed Dec 10, 2025

Montreal, Quebec--(Newsfile Corp. - December 10, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a biotechnology company advancing a proprietary intracellular...

DTCFF : 0.4400 (-8.33%)
DTC.CN : 0.6400 (+1.59%)
Defence Therapeutics Announces Formation of Scientific Advisory Board to Guide Advancement of Accum-Enhanced Antibody Drug Conjugate Programs Newsfile - Thu Dec 4, 2025

Montreal, Quebec--(Newsfile Corp. - December 4, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a biotechnology company advancing a proprietary intracellular...

DTCFF : 0.4400 (-8.33%)
DTC.CN : 0.6400 (+1.59%)
Defence Therapeutics Announces Convertible Debenture Conversion Newsfile - Fri Nov 21, 2025

Montreal, Quebec--(Newsfile Corp. - November 21, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company pioneering next-generation...

DTCFF : 0.4400 (-8.33%)
DTC.CN : 0.6400 (+1.59%)
Defence Therapeutics to Build ADC Drug Delivery Powerhouse Using Its Proprietary Accum Technology Newsfile - Wed Nov 19, 2025

Montreal, Quebec--(Newsfile Corp. - November 19, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company pioneering next-generation...

DTCFF : 0.4400 (-8.33%)
DTC.CN : 0.6400 (+1.59%)

Barchart Exclusives

SoundHound Is One of the Most Short Stocks Right Now. Should You Bet on a SOUN Squeeze? Barchart - 1 hour ago
With over 35% of its float sold short, SoundHound has become one of Wall Street’s most heavily bet-against AI stocks. Is it worth betting on a squeeze ahead? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot